Deborah Knobelman, Ph.D.

Deborah Knobelman, Ph.D.

Former Chief Financial Officer, Treasurer and Head of Corporate DevelopmentatSenti Biosciences Holdings· In proxies 2022–2023

Pay in FY2023-28% from the year before · Senti Biosciences Holdings stock -53.2% the same year

Deborah Knobelman, Ph.D. was paid $789.7K in FY2023 (Dec), down 28%. Senti Biosciences Holdings stock fell 53.2% that year.

Pay$100 in the stock at the end of FY21 → $7
Pay is from the Summary Compensation Table of each Senti Biosciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Senti Biosciences HoldingsPublic company · 4 yr
    • Former Chief Financial Officer, Treasurer and Head of Corporate Development2022 – Present · 4 yrStock in role -100%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?